Pacer Advisors
CRMD icon

Pacer Advisors’s CorMedix CRMD Stock Holding History

Pacer Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Buy
633,978
+53,358
+9% +$422K 0.01% 694
2026
Q1 		$3.94M Buy
580,620
+326,724
+129% +$2.42M 0.01% 684
2025
Q4 		$2.95M Buy
+253,896
New +$2.81M 0.01% 898

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pacer Advisors's CRMD Position: Q2 2026 in Review

Pacer Advisors increased its CorMedix (CRMD) stake by 9.2% in Q2 2026, buying an estimated $422K and bringing the position to 633,978 shares worth $4.98M. The position accounts for 0.01% of the portfolio, ranked #694.

Pacer Advisors first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Pacer Advisors held 633,978 shares of CorMedix worth $4.98M as of Q2 2026.
  • Pacer Advisors bought 53,358 CorMedix shares in Q2 2026, an estimated $422K.
  • CorMedix made up 0.01% of Pacer Advisors's portfolio in Q2 2026, its #694 holding.
  • Pacer Advisors first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.